TOP1 and cancer: We also assessed 7 cancer cell lines with different CUL4A and B expressions and observed an inverse correlation between CUL4 protein levels and SN38 sensitivity (Supplementary Data Fig. 4g, h), indicating CUL4 proteins as potential predictive biomarkers for TOP1 inhibitors.